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aAbstract / Annals of Physical and Reha
ever before have there been so many clinical trials and human studies exa-
ining a wide range of therapeutic approaches for the treatment of spinal cord
njury (SCI). The therapeutic interventions include: 1) drugs to limit the degree of
econdary cell damage after the primary mechanical trauma of SCI, 2) monoclo-
al antibodies to promote axonal sprouting and neuroplasticity, 3) cell transplants
o replace lost neural cells, and 4) activity dependent rehabilitation to facilitate
unctional recovery. The current status for each of these therapeutic approaches,
s well as the strengths and limitations (benefits and risks) for each type of inter-
ention will be summarized. Potential therapeutic options for the future will
lso be discussed, including combination treatments. With increased access to
cientific and medical information via the Internet, patients are now very well
nformed. Consequently, all scientists and clinicians need to answer a wider
cope of questions, ranging from fundamental cell biology to the many claims
or clinical benefits from a seemingly endless number of treatment options. In
rief, all biomedical researchers and health care professionals must now be com-
etent knowledge translators. This means scientists and clinicians must be able
o critically evaluate the quality and strength of evidence provided by different
ypes of preclinical discoveries and human studies, as well as their realistic pros-
ect for clinical application. In brief, human studies without appropriate control
ata and blinded assessments are not pivotal clinical trials and will not vali-
ate an intervention as a treatment. Payment (by a subject) for an experimental
reatment automatically means it is not a clinical trial, as the investigator has
financial incentive (i.e. a bias). The optimal foundations for an ideal clinical
rial program are difficult to guarantee, but several fundamental factors will be
eviewed.
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eurological diseases are often due to a loss of cells and/or interruption of
euronal circuits. Moreover, the central nervous system, thus the spinal cord,
as a limited ability to regenerate spontaneously.
tem cells (SC) are not only able to self-renew but also to produce all cell
ypes. Their transplantation into the injured spinal cord is thus considered as a
herapeutic strategy with the final goal of reducing or even abrogate symptoms.
deally, the CS could be used to generate new neurons to replace those that were
ost. In SCI, the simple replacement is not sufficient to restore lost functions;
ew neurons indeed need to reconnect to their intra-or extra-medullary targets.
t seems, at least in a near future, more feasible to use cell transplantation to
rotect dying neurons, to promote their survival, and possibly to stimulate their
egrowth.
ell transplants already performed in humans have unfortunately brought disap-
ointing results. Parallel studies in animals and humans show that cell transplants
ould increase the incidence of neuropathic pain and worsen the neurological
utcomes.
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ervical spinal cord injuries (SCI) frequently induce, in addition to para and
etraplegia, respiratory insufficiencies that constitute major complicating factors
y increasing dependency (assisted ventilation) and probability of post-trauma
eath.
n order to counterbalance respiratory deleterious effects after cervical SCI, we
ested the impact of intra-spinal transplantation of nasal olfactory ensheathing
ells (OEC), a strategy considered as promising for spinal cord repair.
t the respiratory level, our research group set the stage in evidencing
respiratory benefit after acute cervical SCI and OEC transplantation
1].
n the present report, nasal OEC transplantation was performed in conditions
lose to clinical situations, i.e. after a chronic contusion/compression of the
ervical spinal cord [2]. We used a rat model that mimics the mechanisms
ncountered after a C2 cervical contusion/compression that induces a persistent
emi-diaphragmatic paralysis [3]. The respiratory rat model has been used
ince it has now been established that the rodent constitutes an appropriate
reclinical model for treating spinal cord injury, at least for respiratory dysfunc-
ion [4]. In addition, the therapeutic efficiency of nasal OECs injection within
he injured spinal cord was assessed using a delayed transplantation (2 weeks
ost-contusion).
unctional recovery was quantified with respiratory behavior tests, diaphragma-
ic electromyography and neuro-electrophysiological recording of the phrenic
otoneurons while axogenesis was evaluated using immunohistochemistry.
e show that 3 months post-transplantation (i.e. 3.5 months post-injury), nasal
ECs improve i) breathing movements, ii) activities of the ipsilateral diaphragm
nd corresponding phrenic nerve, iii) axonal sprouting in the injury site and
v) the injured area by reducing the cystic size cavities. We also demonstrate
hat this functional partial recovery is mediated by the restoration of ipsilateral
upraspinal command.
n conclusion, this study brings further evidence that olfactory ensheathing cells
ould have clinical application, especially for tetraplegic patients with impaired
reathing movements.
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ultiple sclerosis (MS) is an inflammatory disease of the central nervous sys-
em (CNS) mainly affecting young adults and responsible for demyelinated
atches within the white matter. The existence of an animal model, the experi-
ental acute encephalomyelitis (EAE) based on the immunization of an animal
ith a myelin peptide or protein allowed a better understanding of the cellular
nd molecular actors playing a role in the MS lesions. Thus, peripheral activa-
ion of CD4 + autoreactive T lymphocytes appeared to be a key phenomenon in
he human disease. However, the animal model presents many shortcomings in
xplaining the pathophysiology of MS. Human studies on the blood, cerebrospi-
al fluid or biopsy/autopsic samples are therefore required to better understand
he lesion formation in MS. These studies have thus showed that CD8 + T lym-
hocytes rather than CD4+ T cells probably had a crucial role in MS injury.
ore recently, the involvement of B cells has been demonstrated. Taken toge-
her, from an immunological point of view, the disease appears more complex
han expected. Finally, recent advances in the field of genetics helped discover
bout 50 genes involved in the occurrence of the disease, the majority of them
aving a role in the immune system. Nevertheless, there are still many disco-
eries to be made to modelize MS lesions, in particular the discovery of the
ntigens responsible for the disease. Indeed while the classical hypothesis of
he emergence of MS is a peripheral immunization against CNS antigens, some
